Osteoporosis

Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report

D. M. Eddy, Jr Johnston C.C., S. R. Cummings, B. Dawson-Hughes, R. Lindsay, L. J. Melton, C. W. Slemenda

Research output: Contribution to journalArticle

246 Citations (Scopus)

Abstract

This report describes evidence for the diagnosis, prevention, and treatment of osteoporosis in postmenopausal healthy white women. Osteoporosis is becoming an increasingly important public health problem as our population ages. Although it is partially preventable, fractures related to osteoporosis are still common. Because of the economic and social burdens, comprehensive prevention programs are needed. Insufficient data prevent development of comparable analyses for men or nonwhite women. Discussed are the effectiveness, risks, and costs of diagnostic tests and treatments, the probabilities that women will have osteoporosis-related fractures, and the effects of various factors on these probabilities. Hormone replacement therapy is considered most cost-effective; women who refuse hormone replacement can consider bisphosphonates (alendronate) and calcitonin. Nomograms are presented for guiding treatment and testing decisions for individual patients. The following public health measures are recommended: Ensure that adults receive the optimal daily intake of calcium - between 1000 mg and 1500 mg; ensure that people at risk for vitamin D deficiency receive 400 IU to 800 IU of vitamin D daily; inform people that exercise, in addition to its other benefits, should help prevent osteoporosis; and discourage people from smoking.

Original languageEnglish (US)
JournalOsteoporosis International
Volume8
Issue numberSUPPL. 4
StatePublished - 1998
Externally publishedYes

Fingerprint

Health Care Costs
Osteoporosis
Cost-Benefit Analysis
Public Health
Alendronate
Nomograms
Postmenopausal Osteoporosis
Vitamin D Deficiency
Hormone Replacement Therapy
Diphosphonates
Calcitonin
Routine Diagnostic Tests
Vitamin D
Therapeutics
Smoking
Economics
Hormones
Exercise
Calcium
Costs and Cost Analysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Eddy, D. M., Johnston C.C., J., Cummings, S. R., Dawson-Hughes, B., Lindsay, R., Melton, L. J., & Slemenda, C. W. (1998). Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report. Osteoporosis International, 8(SUPPL. 4).

Osteoporosis : Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report. / Eddy, D. M.; Johnston C.C., Jr; Cummings, S. R.; Dawson-Hughes, B.; Lindsay, R.; Melton, L. J.; Slemenda, C. W.

In: Osteoporosis International, Vol. 8, No. SUPPL. 4, 1998.

Research output: Contribution to journalArticle

Eddy, DM, Johnston C.C., J, Cummings, SR, Dawson-Hughes, B, Lindsay, R, Melton, LJ & Slemenda, CW 1998, 'Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report', Osteoporosis International, vol. 8, no. SUPPL. 4.
Eddy DM, Johnston C.C. J, Cummings SR, Dawson-Hughes B, Lindsay R, Melton LJ et al. Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report. Osteoporosis International. 1998;8(SUPPL. 4).
Eddy, D. M. ; Johnston C.C., Jr ; Cummings, S. R. ; Dawson-Hughes, B. ; Lindsay, R. ; Melton, L. J. ; Slemenda, C. W. / Osteoporosis : Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report. In: Osteoporosis International. 1998 ; Vol. 8, No. SUPPL. 4.
@article{e823b3576d5840979a2333e43f83be65,
title = "Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report",
abstract = "This report describes evidence for the diagnosis, prevention, and treatment of osteoporosis in postmenopausal healthy white women. Osteoporosis is becoming an increasingly important public health problem as our population ages. Although it is partially preventable, fractures related to osteoporosis are still common. Because of the economic and social burdens, comprehensive prevention programs are needed. Insufficient data prevent development of comparable analyses for men or nonwhite women. Discussed are the effectiveness, risks, and costs of diagnostic tests and treatments, the probabilities that women will have osteoporosis-related fractures, and the effects of various factors on these probabilities. Hormone replacement therapy is considered most cost-effective; women who refuse hormone replacement can consider bisphosphonates (alendronate) and calcitonin. Nomograms are presented for guiding treatment and testing decisions for individual patients. The following public health measures are recommended: Ensure that adults receive the optimal daily intake of calcium - between 1000 mg and 1500 mg; ensure that people at risk for vitamin D deficiency receive 400 IU to 800 IU of vitamin D daily; inform people that exercise, in addition to its other benefits, should help prevent osteoporosis; and discourage people from smoking.",
author = "Eddy, {D. M.} and {Johnston C.C.}, Jr and Cummings, {S. R.} and B. Dawson-Hughes and R. Lindsay and Melton, {L. J.} and Slemenda, {C. W.}",
year = "1998",
language = "English (US)",
volume = "8",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer London",
number = "SUPPL. 4",

}

TY - JOUR

T1 - Osteoporosis

T2 - Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report

AU - Eddy, D. M.

AU - Johnston C.C., Jr

AU - Cummings, S. R.

AU - Dawson-Hughes, B.

AU - Lindsay, R.

AU - Melton, L. J.

AU - Slemenda, C. W.

PY - 1998

Y1 - 1998

N2 - This report describes evidence for the diagnosis, prevention, and treatment of osteoporosis in postmenopausal healthy white women. Osteoporosis is becoming an increasingly important public health problem as our population ages. Although it is partially preventable, fractures related to osteoporosis are still common. Because of the economic and social burdens, comprehensive prevention programs are needed. Insufficient data prevent development of comparable analyses for men or nonwhite women. Discussed are the effectiveness, risks, and costs of diagnostic tests and treatments, the probabilities that women will have osteoporosis-related fractures, and the effects of various factors on these probabilities. Hormone replacement therapy is considered most cost-effective; women who refuse hormone replacement can consider bisphosphonates (alendronate) and calcitonin. Nomograms are presented for guiding treatment and testing decisions for individual patients. The following public health measures are recommended: Ensure that adults receive the optimal daily intake of calcium - between 1000 mg and 1500 mg; ensure that people at risk for vitamin D deficiency receive 400 IU to 800 IU of vitamin D daily; inform people that exercise, in addition to its other benefits, should help prevent osteoporosis; and discourage people from smoking.

AB - This report describes evidence for the diagnosis, prevention, and treatment of osteoporosis in postmenopausal healthy white women. Osteoporosis is becoming an increasingly important public health problem as our population ages. Although it is partially preventable, fractures related to osteoporosis are still common. Because of the economic and social burdens, comprehensive prevention programs are needed. Insufficient data prevent development of comparable analyses for men or nonwhite women. Discussed are the effectiveness, risks, and costs of diagnostic tests and treatments, the probabilities that women will have osteoporosis-related fractures, and the effects of various factors on these probabilities. Hormone replacement therapy is considered most cost-effective; women who refuse hormone replacement can consider bisphosphonates (alendronate) and calcitonin. Nomograms are presented for guiding treatment and testing decisions for individual patients. The following public health measures are recommended: Ensure that adults receive the optimal daily intake of calcium - between 1000 mg and 1500 mg; ensure that people at risk for vitamin D deficiency receive 400 IU to 800 IU of vitamin D daily; inform people that exercise, in addition to its other benefits, should help prevent osteoporosis; and discourage people from smoking.

UR - http://www.scopus.com/inward/record.url?scp=0031791703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031791703&partnerID=8YFLogxK

M3 - Article

VL - 8

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - SUPPL. 4

ER -